Duos Technologies And 2 Other Stocks Under $3 Insiders Are Buying
The Dow Jones index closed higher by 0.2% on Tuesday. When insiders purchase or sell shares, it indicates…
12 Health Care Stocks Moving In Thursday’s After-Market Session
Gainers Ontrak (NASDAQ:OTRK) shares increased by 18.7% to $0.45 during Thursday’s after-market session. The company’s market cap stands…
Ocuphire Pharma Announces First Patient Enrolled In LYNX-2 Phase 3 Study Evaluating Phentolamine Ophthalmic Solution 0.75% (PS) For The Treatment Of Decreased Visual Acuity Under Low Light Conditions Following Keratorefractive Surgery
LYNX-2 Follows SPA Agreement with FDA Development of PS is Funded by Ocuphire's Partner ViatrisFARMINGTON HILLS, Mich., April 11, 2024 (GLOBE NEWSWIRE) -- Ocuphire Pharma, Inc. (NASDAQ:OCUP), a clinical-stage
Ocuphire Pharma Strengthens Leadership Team with Key Appointments; Nirav Jhaveri, C.F.A, M.B.A. Appointed As Chief Financial Officer
Ash Jayagopal, Ph.D., M.B.A. Appointed Chief Scientific and Development Officer Nirav Jhaveri, C.F.A, M.B.A. Appointed as Chief Financial OfficerFARMINGTON HILLS, Mich., Feb. 14, 2024 (GLOBE NEWSWIRE) -- Ocuphire
Ocuphire Pharma Announces Presentation On APX3330 At The Annual Angiogenesis, Exudation, And Degeneration 2024 Conference
Ocuphire Pharma, Inc. (NASDAQ:OCUP), a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing small-molecule therapies for the treatment of retinal and refractive eye disorders,
Ocuphire Pharma Announces Appointment Of Joseph Schachle, M.B.A., As Chief Operating Officer
Ocuphire Pharma, Inc. (NASDAQ:OCUP), a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing small-molecule therapies for the treatment of retinal and refractive eye disorders,
A Look Into Healthcare Sector Value Stocks
Understanding Value Stocks A value stock is traditionally defined in terms of how investors in the marketplace are…
Recap: Ocuphire Pharma Q3 Earnings
Ocuphire Pharma (NASDAQ:OCUP) reported its Q3 earnings results on Monday, November 13, 2023 at 08:00 AM. Here’s what…
Overview Of Value Stocks In The Healthcare Sector
What Defines a Value Stock? A value stock traditionally has a lower price when compared to stock prices…
Ocuphire Pharma Announces Appointment Of George Magrath, M.D., M.B.A., M.S., As Chief Executive Officer And Director
Ocuphire Pharma, Inc. (NASDAQ:OCUP), a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing small-molecule therapies for the treatment of retinal and refractive eye disorders,